• Another interesting interaction concerns NMDA

  2024-01-11

  

  Another interesting interaction concerns NMDA preconditioning to protect against glutamate neurotoxicity. It has been shown that an A1R antagonist prevented neuroprotection evoked by NMDA preconditioning against glutamate-induced cellular damage in cerebellar granule cells. In this study, the functi

• br Acknowledgements br Introduction Autoantibodies directed

  2024-01-11

  

  Acknowledgements Introduction Autoantibodies directed at neurotransmitter receptors and ion channels are pathogenic and/or biomarkers in several autoimmune neurological diseases [1]. For example, autoantibodies directed against voltage-gated potassium channels, the P/Q-type (α1A) voltage-gated

• br The embryological and physiological

  2024-01-10

  

  The embryological and physiological roles of ATX ATX is a vital enzyme that is needed for early embryological development. ATX knockout (KO) (ENPP2−/−) embryos die in utero on average at day 9.5 with vascular and neural tube defects [30], [73], [74], [75]. In these mice, malformations in the alla

• br Autophagy in cancer br Phytochemicals as a valuable

  2024-01-10

  

  Autophagy in cancer Phytochemicals as a valuable source of autophagy modulation agents Epidemiological studies demonstrated that there is a strong association between diet and human cancer mortality so that daily consumption of phytochemicals declines the incidence of different types of cancer

• br Conflicts of interest br Acknowledgments The

  2024-01-10

  

  Conflicts of interest Acknowledgments The authors acknowledge National Institute for Medical Research Development (NIMAD) project no. 940943 and National Research Institute for Science Policy (NRISP) no. 1456 for financial support of this work. AM appreciates National Institute for Genetic Eng

• Because of the formation of phosphoenzyme intermediates

  2024-01-10

  

  Because of the formation of phosphoenzyme intermediates, the enzymatic auda mg of P-ATPases can be divided into steps that include a kinase activity, by which an aspartate residue on the enzyme is phosphorylated, and a phosphatase activity, by which the phosphoenzyme is dephosphorylated. Another co

• To further address the mechanism of Didox s suppressive effe

  2024-01-10

  

  To further address the mechanism of Didox’s suppressive effects on mast cell activation, FceRI receptor nebivolol hcl and downstream transcription factor induction were assessed. We found that Didox had no effect on FceRI surface expression, and thus concluded that Didox effects must be occurring d

• Regardless of the initial treatment most patients with advan

  2024-01-10

  

  Regardless of the initial treatment, most patients with advanced NSCLC experience relapse and disease progression [15]. A subpopulation of immediate concern and clinical need is patients who have advanced NSCLC that is especially aggressive, which is usually defined as disease that rapidly progresse

• Hyperactivity of the hypothalamus pituitary adrenal HPA axis

  2024-01-10

  

  Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis, which is well described in MDD (Pariante and Lightman, 2008, Marques et al., 2009), is also observed in AD and results in increased glucocorticoid (GC, cortisol in primates) levels in blood and CSF (Davis et al., 1986, Martignoni et al.

• br Disclosure br Acknowledgments br Introduction Anaplastic

  2024-01-10

  

  Disclosure Acknowledgments Introduction Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase, belongs to the insulin receptor kinase subfamily [1]. Oncogenic activation of ALK is associated with the naloxone hydrochloride and progression of multiple human cancer types [2,3], includ

• All desired compounds with a carboxylic acid substituent at

  2024-01-10

  

  All desired compounds with a carboxylic 3965 substituent at N1 position of the quinoxalinone scaffold and a variety of aromatic substituents at C3 position were obtained by the syntheses starting from methoxy-substituted 3-chloro-quinoxalin-2(1)-ones () prepared as previously. As shown in , compoun

• Although effects of low concentrations

  2024-01-09

  

  Although effects of low concentrations of agonist were not as thoroughly documented for heteromeric receptors such as the major Okadaic acid mg α4β2 nAChR, a similar mechanism of action was described to explain the potentiation of these receptors with low concentrations of acetylcholine-esterase-in

• br Discussion Here we focused on seven plant alkaloids extra

  2024-01-09

  

  Discussion Here, we focused on seven plant alkaloids extracted from yokukansan. These alkaloids individually inhibited 5-HT-mediated 5-HT3A and 5-HT3AB receptor currents weakly. Simultaneous administration of these alkaloids, however, inhibited the 5-HT3A and 5-HT3AB receptor currents strongly. T

• An AXL decoy receptor with

  2024-01-09

  

  An AXL decoy receptor with enhanced GAS6-binding properties, MYD1, was engineered as a therapeutic tool to disrupt GAS6/AXL signaling in vivo (Kariolis et al., 2014). MYD1 was shown to block metastasis of human ovarian cancer MRS 2578 and a murine breast cancer cell line in grafting assays in mice.

• Phospholipases cleave membrane phospholipids from inflammato

  2024-01-09

  

  Phospholipases cleave membrane phospholipids from inflammatory cells, activated platelets, erythrocytes, adipocytes and cancer GSK2656157 (Aoki et al., 2008, Neidlinger et al., 2006). Several reports have analysed the role of LPA and its receptors in the pathogenesis of RA. Zhao et al. reported th

8492 records 243/567 page Previous Next First page 上5页 241242243244245 下5页 Last page